Skip to main content

Erenumab News

Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine

WEDNESDAY, Sept. 18, 2024 – Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine...

FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine

May 17, 2018 – The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Migraine Prevention, Migraine Prophylaxis, Headache, Migraine

Related drug support groups

Aimovig

Erenumab patient information at Drugs.com